Transthyretin Amyloidosis (ATTR)
Heart Failure Association (HFA) 2026
Congress Details
9-12 May, 2026 | Spain
Barcelona, Spain
The materials in this section are intended for UK healthcare professionals and include scientific and educational congress content related to vutrisiran▼and patisiran. The information contained in these presentations and posters was accurate at the time of presentation. Healthcare professionals should consult the current full Prescribing Information [for the most up-to-date information on indications, dosing, contraindications, warnings, and adverse reactions].
Congress Materials
Presentation Type
Location
Title
Presenter
Sarah Birkhoelzer
Harvard Medical School, MA, USA
University Hospitals Dorset, Bournemouth, UK
Presentation Type
Location
Title
Presenter
Awais Sheikh
National Amyloidosis Centre, London, UK
Presentation Type
Location
Title
Presenter
Jose González-Costello
Bellvitge University Hospital, Barcelona, Spain
Presentation Type
Location
Title
Presenter
Xiaowen Wang
Brigham and Women’s Hospital, MA, USA
Presentation Type
Location
Title
Presenter
Marianna Fontana
National Amyloidosis Centre, London, UK
Presentation Type
Location
Title
Presenter
Arielle Abovich
Brigham and Women’s Hospital, MA, USA
Presentation Type
Location
Title
Presenter
Josephine Mansell
National Amyloidosis Centre, London, UK
